By Abigail Brooks, MA
EnAKT LKD was conducted across 26 CKD programs in Ontario Canada, offering a multi-component intervention designed to target several barriers thought to prevent kidney transplantation and living donation – however, results showed no significant difference between the intervention and usual care groups.
Results from the Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD) trial showed evidence of intervention uptake but no difference in steps completed toward kidney transplantation between the intervention and usual-care groups.
Read the full article in HCP Live.